Carol Suh

Co-founder & VP, Neumora Therapeutics

Partner at ARCH Venture Partners

San Francisco Bay Area, California

About

Female

Carol Suh is the co-founder and vice president, business development of Neumora, and a partner with ARCH Venture Partners. A stem cell biologist by training, Carol combines her scientific expertise with the business side of biotech.

Experience

ARCH Venture Partners

Partner · 2021 – present

View →

31Chicago, Illinois, United StatesFinance · Financial Services

Board Member · HI-Bio
2022 – present
Co-founder & VP · Neumora Therapeutics
2019 – present
Board Member · Orbital Therapeutics

Education

Harvard University · B.A, Molecular and Cellular Biology
Stanford Graduate School of Business · MBA
Yale University · M.Phil, Genetics

Headlines from Google News. Social posts load from the platform only when you open a tab.

40 Under 40: Carol Suh
bizjournals.com · Apr 11
40 Under 40: Nisha Phatak
bizjournals.com · Apr 10
The San Francisco Business Times 40 Under 40 class of 2026
bizjournals.com · Apr 10
Introducing the Business Times' 40 Under 40 class of 2026 - San Francisco Business Times
bizjournals.com · Feb 23
Human Immunology Biosciences Launches to Lead Clinical Immunology into Its Next Chapter with $120 Million Financing
PR Newswire · Nov 1

People at ARCH Venture Partners

Data from: crunchbase